Hemodynamic monitoring systems find extensive usage across hospitals, clinics, ambulatory surgery centers, home care settings, and independent catheterization laboratories. These systems generally include non-invasive blood pressure monitors, vital sign monitors, central venous catheters, pulse oximeters, and pulmonary artery catheters.
The global hemodynamic monitoring systems market is estimated to accrue over US$ 10,846.3 million, in terms of value, by the end of 2027.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/1070
Rising prevalence of congenital heart diseases is a significant growth driver for the global hemodynamic monitoring systems market. According to a study titled ‘Prevalence, profile, and pattern of congenital heart diseases in Central India: A prospective, observational study’, published in May 2018, the prevalence rate of congenital heart diseases (CHDs) was evaluated to be 10.13/1000 live births.
The deep-learning method is increasingly being utilized in the global healthcare space for building different sorts of prediction models. Therefore, the key market players are concentrating on the incorporation of the deep learning method for increasing the stroke volume (SV) estimation by arterial blood pressure. This is an imperative aspect offering lucrative growth opportunities for the global market.
However, the use of hemodynamic monitoring systems brings about certain complications, such as dysrhythmias, balloon rupture, knotting of the catheter, infection, pulmonary infarction, pulmonary artery rupture, and deep vein thrombosis, which is claimed to hinder the global market growth to a great extent.
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1070
Key Market Takeaways:
The pulse oximeters global market segment was assessed at US$ 718.0 million in 2018 and is expected to garner US$ 1,078.6 million by 2027. The segmental growth is accredited to the rising patient population suffering from chronic diseases. Furthermore, the invasive hemodynamic monitoring segment held the foremost position in the global hemodynamic monitoring systems market in 2018, accounting for an impressive 49.4% market share, in terms of volume. Technological advancements and increasing product approvals are factors driving the growth of this segment.
There exists a higher preference for home care settings than that for hospitals, on account of the growing concerns for the geriatric population and relatively higher costs incurred during hospitalization. Thus, the key market players are focused on developing single monitoring platforms. For instance, in July 2019, Caretaker Medical partnered with Mespere LifeSciences to integrate wireless CNIBP, Cerebral Oximetry, and other non-invasive hemodynamic measurements in a single monitoring platform.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1070
Competitive Landscape
The major players operating in the global hemodynamic monitoring system market include Edwards Lifesciences Corporation, ICU Medical, Inc., PULSION Medical Systems SE, Koninklijke Philips N.V., General Electric Company, OMRON Corporation, B. Braun Melsungen AG, LIDCO Ltd., Medtronic, Inc., Drägerwerk AG & Co. KGaA, Nihon Kohden Corporation, Schwarzer Cardiotek GmbH, Osypka Medical GmbH, and Tensys Medical Inc.
In December 2019, Masimo announced that a study published in the Journal of Clinical Monitoring and Computing had successfully evaluated the accuracy of three hemoglobin (Hb) monitoring methods, including the non-invasive, continuous Masimo SpHb. Furthermore, Saranas, Inc. announced the completion of the first U.S. commercial case using its Early Bird Bleed Monitoring System in November 2019. This system aided in real-time detection and monitoring of endovascular bleeding complications.
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1070
Company Profiles:
- Edwards Lifesciences Corporation *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- ICU Medical, Inc.
- PULSION Medical Systems SE
- Koninklijke Philips N.V.
- General Electric Company
- OMRON Corporation
- Braun Melsungen AG
- LIDCO Ltd.
- Medtronic, Inc.
- Drägerwerk AG & Co. KGaA
- Nihon Kohden Corporation
- Schwarzer Cardiotek
- Osypka Medical GmbH
- Tensys Medical Inc.
Browse Press Release: https://bit.ly/36jzknR
Segmentation
Scope of the report
- Hemodynamic Monitoring System Market, By Product Type:
- Vital Sign Monitors
- Pulse Oximeters
- Non-Invasive Blood Pressure Monitors
- Central Venous Catheters
- Pulmonary Artery Catheters
- Hemodynamic Monitoring System Market, By Application:
- Invasive Hemodynamic Monitoring
- Non-Invasive Hemodynamic Monitoring
- Minimally Invasive Hemodynamic Monitoring
- Hemodynamic Monitoring System Market, By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Home Care Settings
- Independent Catheterization Laboratories
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
